Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine, in patients who do not develop any rash, or develop only grade 1 rash, within 4 weeks of start of treatment with gemcitabine + erlotinib, if overall survival can be improved by increasing the dose of erlotinib compared to patients who continue on 100 mg erlotinib.
Inclusion criteria
- Pancreatic cancer